# EDGAR Filing Document

**Accession Number:** 0002048576
**File Stem:** 0002048576-26-000003
**Filing Date:** 2026-4
**Character Count:** 1574
**Document Hash:** 1899ad4fa047d6568e2bad491c482921
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002048576-26-000003.hdr.sgml**: 20260406

**ACCESSION NUMBER**: 0002048576-26-000003

**CONFORMED SUBMISSION TYPE**: C-TR

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260406

**DATE AS OF CHANGE**: 20260406

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Berkshire Biomedical Corp
- **CENTRAL INDEX KEY:** 0002048576

**ORGANIZATION NAME:**
- **EIN:** 873054745
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-TR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35585
- **FILM NUMBER:** 26840750

**BUSINESS ADDRESS:**
- **STREET 1:** 5950 BERKSHIRE LN, STE 375
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225
- **BUSINESS PHONE:** 214-389-1748

**MAIL ADDRESS:**
- **STREET 1:** 5950 BERKSHIRE LN., SUITE 375
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Berkshire Biomedical Corp

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 09-30-2021

**Physical Address:** 5950 BERKSHIRE LN., SUITE 375, DALLAS, TX, 75225

**Issuer Website:** https://www.berkshirebiomedical.com

**Is there a Co-Issuer?:** No

### Signatures

**Issuer:** Berkshire Biomedical Corp

**Signature:** John Edward Timberlake

**Title:** President and CEO

---

**Signature:** John Edward Timberlake

**Title:** President and CEO

**Date:** 04-06-2026